Medical News

Acquired HIV Drug Resistance Among Adults Living with HIV Re...
Antivir. Ther.
The prevalence of acquired HIV drug resistance (HIVDR) was high among patient failing to re-suppress VL and was...
24 May 2022

Evaluation of Inflammation and Atherogenesis Biomarkers Thro...
J. Acquir. Immune Defic. Syndr.
No consistent pattern of change in biomarkers post-switch to dolutegravir + rilpivirine was observed through Weeks...
18 May 2022

Weight Gain During the Dolutegravir Transition in the Africa...
J. Int. AIDS Soc.
Elevated BMI and weight gain among PLWH on TLD are concerning safety signals. Implications for the development of...
18 May 2022

Bictegravir/Emtricitabine/Tenofovir alafenamide in Older Ind...
HIV Med
Switching to B/F/TAF is an effective long-term option for virologically suppressed adults ≥65 years of age, with...
10 May 2022
eCMEs
Key Trials
NADIA Trial: Efficacy and Safety of Dolutegravir or Darunavir in Combination with Lamivudine plus either Zidovudine or Tenofovir for Second line HIV Treatment
NADIA trial assessed efficacy and safety of Dolutegravir or Darunavir in Combination with Lamivudine plus either Zidovudine or Tenofovir for 2nd...
QUATUOR Trial: Efficacy and Safety of a 4-days-on and 3-days-off Maintenance Treatment Strategy for Adults with HIV-1
ANRS 170 QUATUOR trial is the first prospective multicentre randomised trial to investigate the efficacy and safety of a 4-days-on and 3-days-off...
ENCORE 1 Study: Efficacy and Safety of Reduced Dose EFV With Standard Dose EFV In Combination with TDF And FTC As First-Line Treatment for HIV Infection
ENCORE 1 study is the first randomized study comparison of a reduced dose of efavirenz in antiretroviral naive, HIV-infected adults. The 48 weeks...
Impact of Azithromycin on ARES in Children with HIV and Chronic Lung Disease
The present study is the post hoc analysis of BREATHE trial, The analysis aimed to explored the risk factors for acute respiratory exacerbations in...
Our Publications
Antiretroviral-based Prevention Strategies in HIV
Today, antiretroviral therapy (ART) is not only known to keep HIV-infected patients alive but is also being harnessed as a strategy to prevent...
Antiretroviral Therapy – Current Recommendations
Advances in the treatment of HIV infection has resulted in a dramatic shift, from a deadly infectious disease to a chronic manageable condition....
Datasheet: Lopinavir and Ritonavir (40mg/10mg) Oral Pellets
Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This datasheet contains the entire...
Fast Facts: Lopinavir and Ritonavir (40 mg/10 mg) Oral Pellets
Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This booklet contains information about...
Patient Education
Live Healthier, Live Longer
This publication features commonly asked questions by HIV patients regarding HIV therapy, drug side-effects, Do’s and Don’ts while on HIV treatment....
Living with Hope
This publication features common questions which arise in HIV patients mind regarding HIV, diagnosis, transmission, treatment and drug side effects. ...